Airway Management and Weight in Children

Sponsor
University of Michigan (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03996343
Collaborator
(none)
0
1
2
25
0

Study Details

Study Description

Brief Summary

The investigators in this study want to see how overweight/obese children who undergo elective surgery requiring airway management react to general anesthesia. They believe that the incidence of perioperative respiratory adverse events (PRAE) associated with Laryngeal mask airway (LMA) use during general anesthesia in overweight/obese children is lower than that associated with endotracheal intubation (ETT).

Condition or Disease Intervention/Treatment Phase
  • Device: Endotracheal intubation
  • Device: Laryngeal mask airway
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Laryngeal Mask Airway Versus Endotracheal Intubation for Airway Management During General Anesthesia in Obese Children
Anticipated Study Start Date :
May 1, 2019
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Endotracheal intubation

Device: Endotracheal intubation
COMPLETE

Experimental: Laryngeal mask airway

Device: Laryngeal mask airway
COMPLETE

Outcome Measures

Primary Outcome Measures

  1. Severe respiratory adverse events [perioperative period]

    laryngospasm, bronchospasm

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • sex-specific body mass index (BMI) is ≥85th percentile

  • elective surgical outpatient peripheral or lower abdominal procedures

  • Surgery length estimated to last between 30 and 120 minutes

Exclusion Criteria:
  • Active gastro-esophageal reflux, possible difficult intubation or planned asleep fiber optic intubation, cardiac disease, thoracic deformities, upper abdominal, and thoracic or airway surgeries.

  • Children with active asthmatic attack or those considered to be "full stomach" will also be excluded.

  • Laparoscopic surgical procedures and those requiring extreme head-down tilt will also be excluded.

  • Children with a physiology or other condition requiring a certain type of airway for the procedure will also be excluded

  • Children whose anesthesiologist is not agreeable to randomization of airway management choice will also be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Olubukola Nafiu, MD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Olubukola Nafiu, Associate Professor of Anesthesiology, University of Michigan
ClinicalTrials.gov Identifier:
NCT03996343
Other Study ID Numbers:
  • HUM00132290
First Posted:
Jun 24, 2019
Last Update Posted:
Jun 24, 2019
Last Verified:
Jun 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Olubukola Nafiu, Associate Professor of Anesthesiology, University of Michigan

Study Results

No Results Posted as of Jun 24, 2019